Core · 7
MSFT 0.5556 · GOOGL 2 · NVDA 3 · MU 0.79 · STX 1 · BWXT 1 · AMZN 1
Six portfolio companies report before next Monday. One jobs print can move the discount rate. And the least theatrical stock in my nuclear sleeve may have the cleanest chance to earn more weight.
The portfolio began with $5,270. The latest fully reconciled published mark was $8,904, a gain of $3,634 or 69.0%.
The performance percentage remains anchored to the latest fully reconciled book value. I am not inventing an August 1 total while current cash and every brokerage mark remain unverified.
This is the week when a portfolio full of future tense has to start speaking in numbers.
BWXT reports Monday. SpaceX reports Tuesday. Aeva reports Wednesday. D-Wave and Serve report Thursday. MDA reports Friday. Archer and Rocket Lab follow next Monday.
Then Friday morning, the jobs report walks in and changes the discount rate underneath all of them.
That is the real Issue 12 story.
Not the new Microsoft fraction. Not a merger rumor. Not another shiny technology map.
Proof.
Revenue against promises. Backlog against valuation. Cash flow against capital needs. Milestones against calendars that have already moved once.
Friday morning, I deployed exactly $250 at Microsoft’s $450.00 opening price, purchasing 0.5556 shares.
Microsoft closed at $464.72, marking the position at approximately $258.18—up $8.18, or 3.27%, on day one.
The trade is complete. It improves the portfolio’s cash-flow quality and adds another direct route from AI spending to enterprise revenue.
Action: Hold. No second Microsoft purchase this week.
BWXT reports Monday after the close, and it may be the most important decision point in the portfolio—not because one share can move the whole account, but because the company represents the direction I want the account to move.
Frontier exposure with receipts.
BWXT entered the quarter after reporting $860.2 million of first-quarter revenue, $91.2 million of net income and $148.0 million of adjusted EBITDA. Management raised its 2026 outlook to more than $3.75 billion of revenue, adjusted EBITDA of $650 million to $665 million, non-GAAP earnings of $4.60 to $4.75 per share and free cash flow of $315 million to $330 million.
The backlog was approximately $8.65 billion at the end of March, with roughly 60% expected to convert through the end of 2027. That visibility separates BWXT from the portfolio’s pre-revenue nuclear exposure.
Then came the Precision Components Group acquisition.
The deal adds more than 500,000 square feet of U.S. manufacturing capacity, over 450 employees and capabilities in large-envelope machining, heavy weldments, pressure vessels, heat exchangers and ASME-certified components.
That matters because the nuclear thesis is becoming a supply-chain thesis.
Reactors need fuel. They need forgings. They need qualified welds, pressure vessels, specialized machining and factories that cannot be recreated by adding “AI-powered” to a presentation.
BWXT is also carrying momentum from $1.4 billion of naval nuclear-propulsion contracts and progress in TRISO fuel production. The company touches naval reactors, advanced nuclear systems, medical isotopes, microreactors and space power.
That does not make the stock automatically cheap. It makes Monday’s report worth reading properly.
I am prepared to add approximately $100 of BWXT after earnings when guidance is maintained or raised, backlog remains healthy and the stock does not gap more than roughly 5% above Friday’s close.
The better setup would be a 3% to 7% decline caused by integration expenses, timing or conservative commentary—provided the backlog, cash-flow outlook and long-term thesis remain intact.
No add after a material guidance cut, weakening backlog, margin deterioration or evidence that the acquisition is consuming more capital than expected.
MSFT 0.5556 · GOOGL 2 · NVDA 3 · MU 0.79 · STX 1 · BWXT 1 · AMZN 1
ACHR 110 · JOBY 30 · RKLB 5 · PL 12 · MDA 9 · SOFI 10 · ASTS 2
SPCX 1 · CENX 5 · OKLO 2 · SERV 4.5 · AEVA 4 · INTC ≈0.965
QBTS 16
Exited: ARM. Recent risk reductions: SERV cut from 9 shares to 4.5; MU cut from 1.58 shares to 0.79; SPCX previously reduced to 1 share.
Current cash: not fully reconciled. Any proceeds from a coming trade should remain cash until the catalyst wave clears.
Most actionable: BWXT. The report can justify a quality addition.
Largest concentration decision: Archer. Price movement before earnings may create a trim opportunity.
Most important strategic update: Rocket Lab. The Iridium agreement changes both the upside and the balance-sheet risk.
Highest binary risk: D-Wave, Serve and Aeva. Small positions are already doing their job.
Largest macro swing factor: Friday’s jobs report. A hot number can lift yields and punish long-duration names even when company results are fine.
Everything else stays outside the thesis until a filing, formal announcement or credible report appears. A buyout is optional upside. It is not an investment process.
Invalidation: guidance cut, weakening backlog, margin deterioration or acquisition trouble.
Sell 10 shares only if Archer rallies at least roughly 8% before August 10 without a binding contract, meaningful FAA milestone, funded order or other thesis-changing evidence.
This portfolio has trained me to treat empty calendar space like a personal insult.
There is always another launch, filing, earnings call, certification update or company claiming the future has moved into its warehouse.
Next week offers enough action to make overtrading feel like research.
It is not.
The Microsoft trade is done. The speculative earnings positions are already sized. SpaceX is down to one share. Serve has already been cut in half. Micron has already been right-sized.
The only new money decision with a clean quality argument is BWXT—and even that decision waits for Monday’s evidence.
The Archer decision is not about abandoning the thesis. It is about refusing to let a large position get larger merely because the stock gets excited before the company reports.
This week, discipline will look less like finding the perfect stock and more like declining seven invitations to improvise.
The latest fully reconciled tracker remains $8,904 from $5,270—a gain of $3,634, or 69.0%. The current ledger holds 21 positions across Core, Growth, Speculative and Moonshot tiers.
Microsoft added quality, but it is not the center of the week.
BWXT is the clearest potential upgrade. SpaceX must disclose the economics. Aeva, D-Wave and Serve must show commercial progress. MDA must convert backlog. Archer must show certification discipline. Rocket Lab must explain how a larger empire gets financed without weakening the launch business still under construction.
Friday’s jobs report can move all of them at once.
My plan is simple:
Hold Microsoft.
Let BWXT earn a $100 addition.
Use an unsupported Archer rally to reduce concentration.
Keep the binary names small.
Do not confuse a crowded calendar with a mandate to act.
See you next Sunday, buddy. — Alex
One sharp dispatch from the frontier: what changed, what matters, what I'm watching, what the evidence changed — and what the portfolio is doing about it.
No spam. No daily market sludge. Research notes only. Unsubscribe whenever.